![Ragnhild Marie Løberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ragnhild Marie Løberg
No más puestos en curso
Perfil
Ragnhild Marie Løberg formerly worked at Pronova AS, as Director-Galenical Department, Pronova Biocare AS, as Quality Director in 2002, and Algeta ASA, as Senior Vice President-Quality & Regulatory Affairs.
Ms. Løberg received her graduate degree in 1978 from the University of Oslo.
Antiguos cargos conocidos de Ragnhild Marie Løberg.
Empresas | Cargo | Fin |
---|---|---|
Pronova Biocare AS | Corporate Officer/Principal | 01/01/2002 |
ALGETA ASA | Consejero General | - |
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Corporate Officer/Principal | - |
Formación de Ragnhild Marie Løberg.
University of Oslo | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Pronova Biocare AS | |
Pronova AS
![]() Pronova AS Investment Banks/BrokersFinance Part of Norsk Hydro ASA, Pronova AS provides non-marine broking services. | Finance |
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Ragnhild Marie Løberg